上海物貿(600822.SH):2022年度淨利預減63.92%左右
格隆匯1月30日丨上海物貿(600822.SH)公佈,公司預計2022年度實現歸屬於母公司所有者的淨利潤約5330萬元,與上年同期相比減少63.92%左右。公司預計2022年度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤約2946萬元,與上年同期相比減少16.53%左右。
業績預減的主要原因:(一)主營業務影響。主要為2022年疫情對公司汽車貿易、倉儲物流、租賃等業務造成較大不利影響導致利潤下降。(二)非經營性損益的影響。主要為公司2021年轉讓所持有的上海零星危險品化學物流有限公司100%股權而產生投資收益11,991.88萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.